Abstract
We report a case of early gastric cancer and early colon cancer detected by positron emission tomography (PET) cancer screening. A 64-year-old male patient with an unremarkable past history except for hypertension and cerebrovascular disease underwent18F-FDG PET for cancer screening. Images revealed increased uptake in the gastric antrum and sigmoid colon. Both areas appeared suspicious for neoplasm on subsequent fluoroscopy and endoscopy, and biopsies were positive for neoplasia at both sites. The gastric lesion was treated by distal gastrectomy and D2 lymphadenectomy and the colon cancer by endoscopic mucosal resection (EMR). Both surgical specimens were positive for cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yasuda S, Ide M. PET and cancer screening.Ann Nucl Med 2005; 19: 167–177.
Yasuda S, Shohtsu A. Cancer screening with whole-body18F-fluorodeoxyglucose positron-emission tomography.Lancet 1997; 350: 1819.
Dehdashti F, Siegel BA. Neoplasms of the esophagus and stomach.Semin Nucl Med 2004; 34: 198–208.
Yeung HW, Macapinlac H, Karpeh M, Finn RD, Larson SM. Accuracy of FDG-PET in gastric cancer: preliminary experience.Clin Positron Imaging 1998; 4: 213–221.
Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer.World J Surg 2004; 28: 247–253.
Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of18F-FDG PET in patients with a, metastatic, or recurrent gastric cancer.J Nucl Med 2003; 44: 690–699.
Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR. et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.Eur J Nucl Med Mol Imaging 2003; 30: 288–295.
Falk PM, Gupta NC, Thorson AG, Frick MP, Boman BM, Christensen MA, et al. Positron emission tomography for preoperative staging of colorectal carcinoma.Dis Colon Rectum 1994; 37: 153–156.
Abdei-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, et al. Staging of primary colorectal carcinoma with fluorine-18 fluorodeoxyglucose whole body PET: correlation with histopathologic and CT findings.Radiology 1998; 206: 755–760.
Mukai M, Sadahiro S, Yasuda S, Ishida H, Tokunaga N, Tajima T, et al. Preoperative evaluation by whole-body18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer.Oncol Rep 2000; 7: 85–87.
Oku S, Nakagawa K, Momose T, Kumakura Y, Abe A, Watanabe T, et al. FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer.Ann Nucl Med 2002; 16: 409–416.
Kantoroval I, Lipska L, Belohlavek O, Visokai V, Trubae M, Schneiderova M. Routine18F-FDG PET preoperative staging of colorectal cancer; comparison with conventional staging and its impact on treatment decision making.J Nucl Med 2003; 44: 1784–1788.
Chen YK, Kao CH, Liao AC, Shen YY, Su CT. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan.Anticancer Res 2003; 23: 4357–4361.
Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W, Ide M, et al.18F-FDG PET detection of colonic adenomas.J Nucl Med 2001; 42: 989–992.
Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-) malignant colonic abnormalities: endoscopic validation of FDG-PET findings.Eur J Nucl Med 2001; 28: 1766–1769.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaida, H., Ishibashi, M., Nakamura, M. et al. Early gastric cancer and early colon cancer detected simultaneously by PET cancer screening incidentally. Ann Nucl Med 20, 317–320 (2006). https://doi.org/10.1007/BF02984649
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02984649